"
Team:Paris Bettencourt/Patenting
From 2014.igem.org
Marguerite (Talk | contribs) |
|||
| Line 175: | Line 175: | ||
<div id=part1> | <div id=part1> | ||
<p class=text2></p> | <p class=text2></p> | ||
| - | <h6> | + | <h6>iGEM and Patenting</h6><br> |
| - | <p class=text1> | + | <p class=text1>Started based on the idea of open science, iGEM values the sharing of knowledge through the sharing of research data, lab notebook and constructed part. That being said, participating in iGEM means signing a contract to give up the possibility of patenting anything coming directly out of iGEM competition. However, in the past, we have seen commercial products and patenting coming out of ideas started in iGEM, although different methods and biological materials. </p> |
</div> | </div> | ||
<div id=part2> | <div id=part2> | ||
<p class=text2></p> | <p class=text2></p> | ||
| - | <h6> | + | <h6>Why are we talking about patenting?</h6><br> |
| - | <p class=text1> | + | <p class=text1>Since we are not supposed to patent anything coming out of this current stage of the project, why are we talking about patenting here? There are mainly two reasons. </p> |
| + | <p class=text1>First of all, ever since its establishment, biotechnology keeps posting questions to current patenting system. Just last year, we saw the federal court case of patentability of biological constructs. As synthetic biologists, we are curious about both the system and the underlined ethical discussion and wish to learn more about them using this iGEM project as a gateway. </p> | ||
| + | <p class=text1>Second, in the process, as a team, we have talked about and thought about continuing the project with more advanced methods and different bacterial strains and turning it into a commercial product. With this discussion, came the question of legal status. The research on patenting keeps the entrepreneur motivation open. </p> | ||
</div> | </div> | ||
<div id=part3> | <div id=part3> | ||
Revision as of 23:19, 12 October 2014
iGEM and Patenting
Started based on the idea of open science, iGEM values the sharing of knowledge through the sharing of research data, lab notebook and constructed part. That being said, participating in iGEM means signing a contract to give up the possibility of patenting anything coming directly out of iGEM competition. However, in the past, we have seen commercial products and patenting coming out of ideas started in iGEM, although different methods and biological materials.
Why are we talking about patenting?
Since we are not supposed to patent anything coming out of this current stage of the project, why are we talking about patenting here? There are mainly two reasons.
First of all, ever since its establishment, biotechnology keeps posting questions to current patenting system. Just last year, we saw the federal court case of patentability of biological constructs. As synthetic biologists, we are curious about both the system and the underlined ethical discussion and wish to learn more about them using this iGEM project as a gateway.
Second, in the process, as a team, we have talked about and thought about continuing the project with more advanced methods and different bacterial strains and turning it into a commercial product. With this discussion, came the question of legal status. The research on patenting keeps the entrepreneur motivation open.
Part: BBa
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed sit amet laoreet metus, ac viverra dolor. Sed et orci imperdiet sem vulputate ultricies. Aliquam erat volutpat. Cras semper ex non odio aliquet, eget feugiat eros tempor. Integer hendrerit odio et bibendum maximus. Duis scelerisque lacus in odio faucibus fringilla. Nulla eleifend aliquet molestie. Morbi aliquam rhoncus efficitur. Proin consectetur augue aliquam risus convallis egestas. Nunc viverra felis non nibh consequat, nec faucibus ipsum rutrum. Proin placerat faucibus libero vitae dapibus.
Part: BBa
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam eu justo a dolor efficitur laoreet ut at lorem. Fusce dapibus lobortis nisi vehicula porttitor. In volutpat mauris et aliquam pellentesque. Vestibulum fringilla lacus metus, ac ullamcorper lectus sagittis sed. Suspendisse congue magna sed risus molestie aliquam. Sed placerat sagittis volutpat. Phasellus id erat neque. Quisque bibendum iaculis ante et feugiat. In hac habitasse platea dictumst. Fusce placerat lorem vel felis tincidunt, in elementum odio condimentum. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Donec tincidunt bibendum lacus non viverra. Nulla mattis, ante vitae faucibus auctor, mi purus consequat dolor, non malesuada nulla lorem ac odio.
+33 1 44 41 25 22/25
paris-bettencourt-igem@googlegroups.com 
